Phage Biotechnology Corp Company Profile

13:36 EST 12th December 2018 | BioPortfolio

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with research and development laboratories in Kiev, Ukraine. Currently Phage has approximately 75 employees worldwide. The Company was initially formed to manufacture recombinant protein pharmaceuticals as “generic” drugs. This initial focus has been expanded to also include the development of new pegylated forms of existing drugs, as well as single chain antibody pharmaceuticals to treat cancer, arthritis, and auto-immune diseases.
Phage is a biopharmaceutical corporation which manufactures protein pharmaceuticals. The protein pharmaceuticals fall into three main classes, including 1) “bio-similar” versions of marketed drugs whose patents have expired, 2) new drug candidates developed by Phage that will undergo clinical trials, including longer-acting versions of marketed protein products, and 3) a new class of biopharmaceuticals, Single Chain Antibodies, that will compete with monoclonal antibodies for the treatment of cancer, arthritis, and autoimmune diseases. Utilizing a proprietary process, recombinant proteins can be produced with a unique combination of plasmid and bacteriophage technologies. This technology is being applied to the production of key protein pharmaceuticals, with multi-billion dollar estimated market values. Phage plans to manufacture and sell these protein products on a worldwide basis.
As a result of this production advantage, Phage is targeting the production and sale of drugs that no longer have patent protection. It is anticipated that the primary method for developing sales will be to offer buyers of these types of drugs a substantial price discount compared to all other pharmaceutical producers. It is estimated that Phage can discount its sales price for these drugs from between 30% to 50% of the sales price other companies are charging for the identical drugs. Even marketing these drugs at discounted levels will provide Phage with significant profit margins, in large part as a result of the minimal costs associated with manufacturing these drugs utilizing the Phage system. In addition to developing biopharmaceuticals whose patents have expired, Phage is also developing new pegylated versions of these drugs that should substantially increase the marketplace for these drugs. Most protein drugs must be injected, some daily, but pegylated versions of these drugs often go to once-weekly injections due to their much expanded half-life in the body’s circulation.


1635 Village Center CircleSuite 240
Las Vegas
United States of America


Phone: 702/492-6694
Fax: 702/492-9903

News Articles [283 Associated News Articles listed on BioPortfolio]

#jobs #lifescience Paramount Recruitment: Phage Display Scientist – Cambridge – 9 months FTC

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Paramount Recruitment: Phage Display Scientist – Cambridge – 9 mo...

First phage therapy center in the U.S. signals growing acceptance

Phage therapy went out of fashion in the U.S. decades ago. Now a new center at the University of California, San Diego wants to revive it to combat antibiotic-resistant infections.

Phage therapy draws renewed interest to combat drug-resistant microbes

(Children's National Health System) In the face of growing antibiotic resistance and few antibiotics in the development pipeline, phages are drawing renewed research interest as a potential silver bul...

CRISPR-Cas3 Platform Developer Locus Biosciences Acquires EpiBiome Phage Technology

Locus Biosciences, a developer of CRISPR-Cas3-engineered precision antibacterial products, has acquired EpiBiome’s high-throughput bacteriophage phage discovery platform for an undisclosed price, in...

Adaptive Phage Therapeutics Enters into Collaboration Agreement with Researchers at Yale University to Manufacture and Supply Therapeutic Bacteriophage

Adaptive Phage Therapeutics (APT), a clinical-stage biotechnology company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pat...

Antibiotic Development Question: Should A Phage Library Equal One Application?

FDA may have to take a personalized medicine approach when deciding how to classify a phage bank used to create...   

Turning a phage

(University of California - San Diego) With microbial resistance to antibiotics growing into a major global health crisis, researchers at University of California San Diego School of Medicine, in coll...

IONTAS founder and pioneer in phage display technology attends Nobel Prize Award Ceremony

IONTAS Limited (IONTAS), a leader in the discovery and optimization of fully human antibodies, announced its Founder and Chief Executive Officer, John McCafferty was invited to attend the Nobel Prize ...

PubMed Articles [361 Associated PubMed Articles listed on BioPortfolio]

Exploiting Bacteriophage Proteomes: The Hidden Biotechnological Potential.

Bacteriophages encode many distinct proteins for the successful infection of a bacterial host. Each protein plays a specific role in the phage replication cycle, from host recognition, through takeove...

Host range and molecular characterization of a lytic Pradovirus-like Ralstonia phage RsoP1IDN isolated from Indonesia.

A lytic Ralstonia solanacearum-infecting phage designated Ralstonia phage RsoP1IDN was isolated from soil in Indonesia. The phage has a linear double-stranded DNA genome of 41,135 bp with 413-bp termi...

Analysis of phage resistance in Staphylococcus aureus SA003 reveals different binding mechanisms for the closely related Twort-like phages ɸSA012 and ɸSA039.

We have previously generated strains of Staphylococcus aureus SA003 resistant to its specific phage ɸSA012 through a long-term coevolution experiment. However, the DNA mutations responsible for the p...

Display Technologies for Generation of Ig Single Variable Domains.

Variable fragments of heavy-chain-only antibodies (VHH) found in camelids are valuable research tools in pharmacology and biotechnology and are being developed for the clinic to treat patients with au...

Rapid label-free detection of E. coli using a novel SPR biosensor containing a fragment of tail protein from phage lambda.

In efforts to speed up the assessment of microorganisms, researchers have sought to use bacteriophages as a biosensing tool, due to their host-specificity, wide abundance, and safety. However, the lyt...

Clinical Trials [18 Associated Clinical Trials listed on BioPortfolio]

Evaluation and Detection of Facial Propionibacterium Acnes Bacteria and Phage

This multi-center, outpatient study will extract and evaluate the presence of facial P. acnes bacteria and phage strains using pore strips on up to 400 human subjects.

Ascending Dose Study of the Safety of AB-SA01 When Topically Applied to Intact Skin of Healthy Adults

This study will examine the safety of ascending doses of AB-SA01 when topically applied to intact skin of healthy adults.

A Pilot Scheme - Specimen Collection of Health Management Center

Biomedical and biotechnology industry is internationally regarded as the most brilliant star performer of the future. The development of biomedical depends on a high quality academic resea...

Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC

To investigate the predictive value of stathmin expression as a predictive biomarker in OSCC patients, who treated with TPF (docetaxel, cisplatin and 5-fluorouracil ) induction chemotherap...

Bacteriophages for Treating Urinary Tract Infections in Patients Undergoing Transurethral Resection of the Prostate: A Randomized, Placebo-controlled, Double-blind Clinical Trial

Urinary tract infections are among the most prevalent microbial diseases and their financial burden on society is substantial. The use of bacteriophages against bacterial pathogens has gai...

Companies [962 Associated Companies listed on BioPortfolio]

Phage Biotechnology Corp

Phage Biotechnology Corporation (Phage) is a Delaware Corporation, incorporated in 1998 and headquartered in Las Vegas, Nevada. The company has a manufacturing plant in Irvine, California, with resear...

Adaptive Phage Therapeutics (APT)

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogeni...

Vincogen Corporation

Vincogen Corporation is a RF ID Biochip company established in year 2000 and has developed a proprietary radio-frequency (RF) biochip platform and T4 Phage Display platforms for use in several applica...

Special Phage Services

Few inventions in science and medicine have had such a profound effect on human health as the discovery and subsequent development of antibiotics. Following their introduction during World War II ma...

Phage Biotech Ltd.

Phage-Biotech Ltd. was incorporated in March 2000, as a new player in the emerging field of Phage Therapy. The Company’s mission is to develop proprietary Phage-based anti-infective therapeutics to ...

More Information about "Phage Biotechnology Corp" on BioPortfolio

We have published hundreds of Phage Biotechnology Corp news stories on BioPortfolio along with dozens of Phage Biotechnology Corp Clinical Trials and PubMed Articles about Phage Biotechnology Corp for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Phage Biotechnology Corp Companies in our database. You can also find out about relevant Phage Biotechnology Corp Drugs and Medications on this site too.

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Generics Drugs
A generic drug (generic drugs, short: generics) is a drug defined as "a drug product that is comparable to brand/reference listed drug product in dosage form, strength, route of administration, quality and performance characteristics, and intended u...

Corporate Database Quicklinks

Searches Linking to this Company Record